NCT03652701

Brief Summary

The objective of this study is to assess the performance of Hair Up on female pattern hair shedding and regrowth. 58 adult female patients suffering from hair loss will be evaluated in a single center prospective study

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 29, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

April 4, 2019

Status Verified

April 1, 2019

Enrollment Period

11 months

First QC Date

June 27, 2018

Last Update Submit

April 2, 2019

Conditions

Hair Loss

Outcome Measures

Primary Outcomes (1)

  • Assessment of hair loss

    Pull test

    1 month

Secondary Outcomes (2)

  • Assessment of hair regrowth

    3 months

  • Quality of life questionnaire

    3 months

Study Arms (2)

Hair Up

EXPERIMENTAL
Other: Hair Up

Placebo

PLACEBO COMPARATOR
Other: Placebo

Interventions

Hair UpOTHER

Herbal topical

Hair Up
PlaceboOTHER

Placebo

Placebo

Eligibility Criteria

Age25 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women who report hair loss during the past 3 months prior to the study

You may not qualify if:

  • Disorders and medications affecting hair loss/growth, pregnancy, scarring alopecia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Alopecia

Condition Hierarchy (Ancestors)

HypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2018

First Posted

August 29, 2018

Study Start

April 1, 2019

Primary Completion

March 1, 2020

Study Completion

March 1, 2021

Last Updated

April 4, 2019

Record last verified: 2019-04